Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta-blockers and plasma lipids]

C Soulier1, L Merle

  • 1Service de Pharmacologie-Toxicologie, Hôpital Dupuytren, Limoges.

Therapie
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Long-term beta-blocker use for hypertension can negatively impact lipid levels, increasing triglycerides and lowering HDL-cholesterol. Cardioselective or sympathomimetic beta-blockers may offer a more favorable lipid profile.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Introduction of the Couder manoeuvre and perineal injuries].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

Passive samplers for chemical substance monitoring and associated toxicity assessment in water.

Water science and technology : a journal of the International Association on Water Pollution Research·2011
Same author

Potentially inappropriate drug prescription in the elderly in France: a population-based study from the French National Insurance Healthcare system.

European journal of clinical pharmacology·2011
Same author

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Neurology·2009
Same author

Inappropriate medications in the elderly.

Clinical pharmacology and therapeutics·2008
Same author

[Potentially inappropriate medications in the elderly: a list adapted to French medical practice].

La Revue de medecine interne·2008
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism Research

Context:

  • Beta-blockers are a cornerstone in hypertension management.
  • Long-term use may adversely affect lipid profiles, potentially counteracting therapeutic benefits.

Purpose:

  • To investigate the impact of beta-blockers on lipid metabolism.
  • To identify factors influencing the lipid-altering effects of beta-blockers.

Summary:

  • Beta-blocker therapy for hypertension is linked to increased serum triglycerides and decreased high-density lipoprotein (HDL)-cholesterol.
  • Intrinsic sympathomimetic activity or cardioselectivity in beta-blockers may mitigate these unfavorable effects on lipid metabolism.
  • The precise mechanisms underlying these lipid alterations remain incompletely understood.

Related Experiment Videos

Impact:

  • Highlights potential risks of beta-blockers beyond blood pressure reduction.
  • Suggests considering specific beta-blocker properties for patients with dyslipidemia concerns.
  • Underscores the need for further research into the complex mechanisms involved.